A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease Using a Reduced-Intensity Preparatory Regime

Conditions

Other Hematopoietic | Pediatrics | Sickle Cell Disorders

Phase I

Volunteers
Health Professionals

What is the purpose of this trial?

The hypothesis for this study is that a preparative regimen that maximizes host immunosuppression without myeloablation will be well tolerated and sufficient for engraftment of donor hematopoietic cells. It is also to determine major toxicities from these conditioning regimens, within the first 100 days after transplantation.

Find out more about who can participate in this trial

Trial with
NO FUNDING
Start Date
06/22/2018
End Date
12/31/2018

For more information about this study, contact:

Sharon Huie

sharon.huie@yale.edu

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 877.978.8343

Volunteer Now

Principal Investigator

Niketa C Shah, MD
Associate Professor of Pediatrics (Hematology/Oncology); Director,Pediatric Cellular Therapy Program, Pediatric Hematology & Oncology; Director, Pediatric Bone Marrow Transplant Program

Sub-Investigators

Last Updated
07/15/2021
Study HIC
#2000021396

A Study of Hematopoietic Stem Cell Transplantation (HSCT) in Non-Malignant Disease Using a Reduced-Intensity Preparatory Regime

Conditions

Volunteers

Health Professionals

What is the purpose of this trial?

I'm interested in volunteering

Principal Investigator

Sub-Investigators

Contact Information